Completed PHASE4 INTERVENTIONAL 2-arm NCT01050348

To Investigate the Role of Upstream High Dose Statin in STEMI (IMPRES)

A Double Blinded Randomized Placebo Controlled Study: To Investigate the Role of Upstream High Dose Statin Treatment in Patients With ST Segment Elevation Myocardial Infarction

Sponsor: The Western Pennsylvania Hospital

Conditions Acute Myocardial Infarction

Interventions Atorvastatin calcium Inactive Placebo

Updated 8 times since 2017 Last updated: Oct 3, 2018 Started: Jun 30, 2009 Primary completion: Jun 30, 2010 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Myocardial Infarction and is currently completed. The Western Pennsylvania Hospital leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Nov 2018 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Western Pennsylvania Hospital
West Penn Allegheny Health System

Data source: The Western Pennsylvania Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States